MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PAEP | Progestagen-associated endometrial protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
DCX | Doublecortin | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | Predicted intracellular proteins
| | | | | Group enriched |
EMX2 | Empty spiracles homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
TRH | Thyrotropin-releasing hormone | Predicted secreted proteins
| | | | | Tissue enriched |
HOXA11 | Homeobox A11 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CEMIP | Cell migration inducing protein, hyaluronan binding | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GLI1 | GLI family zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXA10 | Homeobox A10 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
IL17RD | Interleukin 17 receptor D | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LONRF2 | LON peptidase N-terminal domain and ring finger 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MEX3A | Mex-3 RNA binding family member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
MSX1 | Msh homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MUC16 | Mucin 16, cell surface associated | Predicted membrane proteins
| | | | | Tissue enhanced |
PLK5 | Polo-like kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SFRP4 | Secreted frizzled-related protein 4 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SOX17 | SRY (sex determining region Y)-box 17 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
STC1 | Stanniocalcin 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SYTL4 | Synaptotagmin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |